CORELOGIC, INC. 4

4 · CORELOGIC, INC. · Filed Jul 1, 2016

Form 4

Period: 2016-06-30

DirectorPresident and CEO*

Transactions

Sale
Common Stock
[F1][F2]
2016-06-30$37.92/sh−20,000$758,438→ 226,046.9 total
Sale
Common Stock
[F1][F3]
2016-06-30$38.08/sh−8,334$317,353→ 70,166 total(indirect: By Trust)
Sale
Common Stock
[F1][F4]
2016-06-30$38.18/sh−8,334$318,195→ 70,166 total(indirect: By Trust)

Holdings

Footnotes (4)

[F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 26, 2016.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.84 to $38.0101, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.98 to $38.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.06 to $38.295, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

Angela Grinstead, attorney-in-fact for Anand Nallathambi|2016-07-01

Documents

1 file